माल्टा - अंग्रेज़ी - Medicines Authority

accord healthcare ireland ltd euro house, euro business park, little island cork, t45 k857, ireland - bupivacaine hydrochloride - solution for injection - bupivacaine hydrochloride 5 mg/ml - anesthetics

माल्टा - अंग्रेज़ी - Medicines Authority

accord healthcare ireland ltd euro house, euro business park, little island cork, t45 k857, ireland - bupivacaine hydrochloride - solution for injection - bupivacaine hydrochloride 5 mg/ml - anesthetics

माल्टा - अंग्रेज़ी - Medicines Authority

accord healthcare ireland ltd euro house, euro business park, little island cork, t45 k857, ireland - bupivacaine hydrochloride - solution for injection - bupivacaine hydrochloride 5 mg/ml - anesthetics

आयरलैंड - अंग्रेज़ी - HPRA (Health Products Regulatory Authority)

noridem enterprises limited - bupivacaine hydrochloride, anhydrous - solution for injection - 2.5 milligram(s)/millilitre - bupivacaine

आयरलैंड - अंग्रेज़ी - HPRA (Health Products Regulatory Authority)

noridem enterprises limited - bupivacaine hydrochloride, anhydrous - solution for injection - 5 milligram(s)/millilitre - bupivacaine

माल्टा - अंग्रेज़ी - Medicines Authority

accord healthcare limited - bupivacaine hydrochloride - solution for injection - bupivacaine hydrochloride 2.5 mg/ml - anesthetics

माल्टा - अंग्रेज़ी - Medicines Authority

accord healthcare limited - bupivacaine hydrochloride - solution for injection - bupivacaine hydrochloride 5 mg/ml - anesthetics

ऑस्ट्रेलिया - अंग्रेज़ी - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - bupivacaine hydrochloride monohydrate, quantity: 52.8 mg - injection, solution - excipient ingredients: water for injections; sodium chloride; hydrochloric acid; sodium hydroxide - bupivacaine injection is indicated for the production of local or regional anaesthesia and analgesia in individuals as follows: surgical anaesthesia - epidural block for surgery - field block (minor and major nerve blocks and infiltration). analgesia - continuous epidural infusion or intermittent bolus epidural administration for analgesia in post operative pain or labour pain. - field block (minor nerve block amd infiltration). the choice of 2 strengths, 0.25% and 0.5%, makes it possible to vary the degree of motor blockade.

संयुक्त राज्य - अंग्रेज़ी - NLM (National Library of Medicine)

huons co., ltd. - bupivacaine hydrochloride (unii: 7tqo7w3vt8) (bupivacaine - unii:y8335394ro) - bupivacaine hydrochloride in dextrose injection, usp is indicated for subarachnoid injection in adults for the production of subarachnoid block (spinal anesthesia). bupivacaine hydrochloride in dextrose injection, usp is contraindicated in: - intravenous regional anesthesia (bier block) [ see warnings and precautions (5.8) ]. - patients with septicemia. - patients with severe hemorrhage, severe hypotension or shock, due to a reduced cardiac output. - patients with clinically significant arrhythmias, such as complete heartblock, due a reduced cardiac output. - patients with a known hypersensitivity to bupivacaine or to any local anesthetic agent of the amide-type or to other components of bupivacaine hydrochloride in dextrose injection, usp. - patients with local infection at the site of proposed lumbar puncture. risk summary the available data on the use of bupivacaine hydrochloride in dextrose injection, usp in pregnant women do not establish the presence or absence of developmental toxicity related

संयुक्त राज्य - अंग्रेज़ी - NLM (National Library of Medicine)

b. braun medical inc. - bupivacaine hydrochloride (unii: 7tqo7w3vt8) (bupivacaine - unii:y8335394ro) - bupivacaine hydrochloride in dextrose injection, usp is indicated for the production of subarachnoid block (spinal anesthesia). standard textbooks should be consulted to determine the accepted procedures and techniques for the administration of spinal anesthesia. bupivacaine hydrochloride in dextrose injection, usp is contraindicated in patients with a known hypersensitivity to it or to any local anesthetic agent of the amide-type. the following conditions preclude the use of spinal anesthesia: - severe hemorrhage, severe hypotension or shock and arrhythmias, such as complete heart block, which severely restrict cardiac output. - local infection at the site of proposed lumbar puncture. - septicemia.